local_hospital

Sante Atlantique

Address
lock Available on a paid plan

Digestive System Diseases

At Sante Atlantique, clinical research in digestive system diseases focuses on Crohn's disease and colorectal cancer, with studies aimed at improving treatment response and surgical outcomes.

  • Testing whether a new therapeutic strategy can improve disease control in Crohn's disease after loss of response to current treatment.
  • Evaluating ways to reduce complications in colorectal surgery by better assessing tissue perfusion during the operation.
  • Supporting more effective care for patients with inflammatory bowel disease and cancer-related digestive conditions.

This area combines medical treatment research with surgical innovation, reflecting a strong interest in both long-term disease management and safer procedures.

Musculoskeletal Diseases

The anesthésie orthopédie department is also studying musculoskeletal diseases, especially acute low back pain, with research focused on better pain relief for recent lumbago.

  • Assessing whether targeted anesthetic blocks can ease pain from muscle contractures in the first days after onset.
  • Exploring improved symptom control for people with acute lumbar pain.
  • Advancing practical approaches to short-term pain management in common back disorders.

This work is centered on improving comfort and recovery through more effective pain management strategies.

Neoplasms

Research in neoplasms at this site includes studies related to colorectal cancer, with a focus on making surgery safer and reducing postoperative complications.

  • Studying whether intraoperative imaging can help surgeons better evaluate blood flow in bowel tissue.
  • Aiming to lower the risk of anastomotic leakage after colorectal surgery.
  • Supporting efforts to improve surgical outcomes for patients with cancer of the colon and rectum.

These trials reflect a strong interest in surgical innovation and in improving the safety of cancer treatment.

Site Overview

assignment
5
connected trials
corporate_fare
4
sponsors
science
5
IMPs

Activity Indicator

Last 6 months

2
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
5
Total trials linked
Active
trending_upGrowing+100%
2
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
5
Sponsors (total)
4
Active sponsors
4

Sponsor Network

Top 4 by active trials.

lock +3 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 978 other sites in France

description
Trial volume
5
Outperforms 63% of sites
public
Therapeutic diversity
4areas
Outperforms 69% of sites
groups
Sponsor diversity
4sponsors
Outperforms 62% of sites

Therapeutic Area Benchmark — France

Select a therapeutic area to compare against other sites in France.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: France

Market Share

Country: France

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Sante Atlantique

lock Showing 1 of 5 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Efficacy of Vedolizumab Versus Adalimumab Dose Intensification in Crohn's Disease Patients with Secondary Loss of Response to AdalimumabCentre Hospitalier Universitaire De Saint EtiennePhase IIIRecruitingMay 2024

IMP list

lock Showing 1 of 5 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Adalimumab1Unknown2024-05-272024-05-27

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.